Skip to content

Targets proliferate in HIV cure research

Dr Daniel Kuritzkes of Harvard Medical School gives keynote address: Progress and challenges in HIV cure research. Image by: Marcus Rose/IAS.

No HIV infections from partners with fully suppressed viral load during long-term follow up of landmark treatment as prevention trial

Myron Cohen at IAS 2015. Photo ©Steve Forrest/Workers' Photos/IAS

Young woman stays undetectable for twelve years off treatment after early HIV therapy

Dr Asier Saez-Cirion speaking at the Towards an HIV Cure symposium. Photo ©Steve Forrest/Workers' Photos/IAS.

Presumptive treatment of TB in advanced HIV no better than giving ART and isoniazid

Access to screening and treatment are key issues for hepatitis B and C and HIV/viral hepatitis co-infection

Panel on hepatitis treatment access. Photo by Liz Highleyman, hivandhepatitis.com

Vancouver Consensus Statement calls for early access to treatment and PrEP worldwide

Conference co-chair, Julio Montaner, at the Opening Session of IAS 2015, with a Native blanket received as a gift. Photo ©Steve Forrest/Workers' Photos/IAS

World Health Organization urges more HIV testing by non-medical staff, outside of clinical settings, targeted to those who need it the most

Cheryl Johnson, World Health Organization, presenting at IAS 2015. Photo by Liz Highleyman, hivandhepatitis.com

World Health Organization to recommend HIV treatment for all

Image from presentation given by Dr Meg Doherty of the WHO Department of HIV/AIDS at IAS 2015.

Test and treat studies and African countries showing that 90-90-90 targets are achievable

Michel Sidibé, executive director of UNAIDS, speaking at the International HIV Treatment as Prevention Workshop. Image by www.treatmentaspreventionworkshop.org